Medicare Enrolled

Dr. Allison Graziadei, MD

Endocrinology · Halfmoon, NY
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
1783 ROUTE 9 STE 203, Halfmoon, NY 12065
5182136910
In practice since 2008 (18 years)
NPI: 1265694871 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Graziadei from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Graziadei? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Graziadei

Dr. Allison Graziadei is an endocrinology specialist in Halfmoon, NY, with 18 years of NPI registration. Based on federal Medicare data, Dr. Graziadei performed 6,421 Medicare services across 1,126 unique beneficiaries.

Between the years covered by Open Payments, Dr. Graziadei received a total of $6,066 from 19 pharmaceutical and/or device companies across 258 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Graziadei is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 11% volume in NY $6,066 industry payments

Medicare Practice Summary

Medicare Utilization ↗
6,421
Medicare services
Top 11% in NY for endocrinology
1,126
Unique beneficiaries
$24
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~357 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 4,440 $18 $38
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
302 $87 $210
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
157 $10 $50
Comprehensive metabolic blood panel
A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers.
146 $10 $32
Thyroid stimulating hormone (TSH) test
A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function.
146 $16 $48
Free thyroxine (T4) test
A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream.
145 $9 $26
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
142 $8 $20
Vitamin D level test
A blood test to measure the amount of Vitamin D-3 in your body.
128 $29 $82
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
127 $126 $283
Hemoglobin A1c test (diabetes monitoring)
A blood test that measures your average blood sugar levels over the past two to three months.
82 $10 $30
Lipid panel (cholesterol and triglycerides)
A blood test that measures cholesterol and triglyceride levels.
76 $13 $40
Urine microalbumin test (kidney screening)
A laboratory test that measures the amount of microalbumin, a small protein, in a urine sample. This test is used to detect early signs of kidney damage.
70 $6 $18
Creatinine test (kidney function)
A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury.
70 $5 $13
Parathyroid hormone level test
A blood test that measures the amount of parathyroid hormone in your body. This hormone helps regulate calcium levels in the blood and bones.
65 $40 $113
Magnesium level test
A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess.
59 $7 $19
Phosphate level test
A blood test that measures the amount of phosphate in your body. Phosphate is a mineral that helps keep bones and teeth strong.
46 $5 $13
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
45 $22 $86
Kidney function blood test panel 36 $9 $24
New patient office visit, complex (60-74 min) 33 $151 $405
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
27 $69 $141
Prolonged office E/M service, first 15 minutes
This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service.
20 $25 $66
Basic metabolic blood panel
A blood test that measures a group of basic chemicals, including total calcium levels.
15 $8 $25
Microsomal antibody test
A blood test that measures the level of microsomal antibodies, which are autoantibodies produced by the immune system.
15 $14 $41
Thyroglobulin antibody blood test
A blood test that measures the level of antibodies against thyroglobulin, a protein produced by the thyroid gland.
15 $16 $47
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
14 $118 $324
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,066
Total received (2018-2024)
Avg $867/year across 7 years
Top 27% in NY for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
19
Companies
258
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,043 (99.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$23 (0.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$276
2023
$737
2022
$1,010
2021
$710
2020
$437
2019
$1,256
2018
$1,640

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$136
Tolmar, Inc.
$49
Tandem Diabetes Care, Inc.
$27
Novo Nordisk Inc
$24
Antares Pharma, Inc.
$20
Dexcom, Inc.
$20
Top 3 companies account for 77.0% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,448
Novo Nordisk Inc
$1,257
Medtronic MiniMed, Inc.
$620
Lilly USA, LLC
$454
Medtronic, Inc.
$409
Boehringer Ingelheim Pharmaceuticals, Inc.
$407
AstraZeneca Pharmaceuticals LP
$297
Insulet Corporation
$250
SANOFI-AVENTIS U.S. LLC
$146
Tandem Diabetes Care, Inc.
$134
Esperion Therapeutics, Inc.
$118
Supernus Pharmaceuticals, Inc.
$117
Abbott Laboratories
$106
Antares Pharma, Inc.
$75
Dexcom, Inc.
$73
Radius Health, Inc.
$61
Tolmar, Inc.
$49
PFIZER INC.
$23
Senseonics, Incorporated
$23
Top 3 companies account for 54.8% of all-time payments
Associated products mentioned in payments ›
Aimovig · BAQSIMI · Dexcom CGM · Dexcom G6 Transmitter · EVENITY · Eversense · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · Guardian Connect · InPen · JARDIANCE · JATENZO · Levemir · MINIMED 630G · MINIMED 780G · MOUNJARO · Minimed 630G · Minimed 670G System · Minimed 770G System · NEXLIZET · NOCDURNA · Omnipod · Ozempic · Prolia · RYBELSUS · Repatha · Rybelsus · SOMAVERT · SYNJARDY · TOUJEO · TRADJENTA · TROKENDI XR · TRULICITY · TZIELD · Tresiba · Tymlos · Wegovy · XYOSTED · Xultophy 100/3.6 · ZEPBOUND · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an endocrinology specialist in Halfmoon?
Compare endocrinologists in the Halfmoon area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
35
Per 100K population
14.8
County median income
$99,653
Nearest hospital
ELLIS HOSPITAL
7.2 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Graziadei is a mixed practice specialist, with above-average Medicare volume (top 11% in NY), with low-engagement industry engagement, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Graziadei experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Graziadei performed 4,440 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Graziadei receive payments from pharmaceutical companies?
Yes. Dr. Graziadei received a total of $6,066 from 19 companies across 258 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Graziadei's costs compare to other endocrinologists in Halfmoon?
Dr. Graziadei's average Medicare payment per service is $24. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Graziadei) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →